It could be the first new treatment for gonorrhea in 30 years. It could be the first new treatment for the infection in 30 ...

(NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) for the treatment of adults and adolescents aged 12 years and older with ...

TIME Reveals the 2025 TIME100 List of the 100 Most Influential People in the World The issue has five worldwide covers, ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new targeted drug for the inflammatory skin disease in over a decade, drugmakers ...

“Oh and there’s just one more thing, doctor …” This offhand comment at the end of a visit to the GP is often the start of the ...

A North Texas hospital system has filed a lawsuit over insulin pricing, joining a growing rank of plaintiffs who are suing manufacturers and others on the grounds of inflating prices of the vital drug ...

Paris and Tarrytown, NY, April 18, 2025. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adults and adolescents aged 12 years and older with chronic ...

Learn how and where to inject Zepbound and where to get additional help. Plus, get tips for injecting the drug at home and ...

Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden ...

LITTLE ROCK, Ark. (AP) — Arkansas Republican Gov. Sarah Huckabee Sanders said Friday that she's not in a rush to resume executions after signing legislation allowing the use of nitrogen gas to put ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

Dupixent is the first new targeted therapy to receive FDA-approval for chronic spontaneous urticaria in adults and ...